BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 17029218)

  • 1. The presence of an intronic deletion in p73 and high levels of ZEB1 alter the TAp73/DeltaTAp73 ratio in colorectal carcinomas.
    Domínguez G; Peña C; Silva J; García JM; García V; Rodríguez R; Cantos B; Citores MJ; España P; Bonilla F
    J Pathol; 2006 Dec; 210(4):390-7. PubMed ID: 17029218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DeltaTAp73 upregulation correlates with poor prognosis in human tumors: putative in vivo network involving p73 isoforms, p53, and E2F-1.
    Domínguez G; García JM; Peña C; Silva J; García V; Martínez L; Maximiano C; Gómez ME; Rivera JA; García-Andrade C; Bonilla F
    J Clin Oncol; 2006 Feb; 24(5):805-15. PubMed ID: 16380414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of N-terminally truncated variants of p73, deltaTAp73, in head and neck squamous cell cancer: a comparison with p53 mutations.
    Faridoni-Laurens L; Tourpin S; Alsafadi S; Barrois M; Temam S; Janot F; Koscielny S; Bosq J; Bénard J; Ahomadegbe JC
    Cell Cycle; 2008 Jun; 7(11):1587-96. PubMed ID: 18469517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulating p73 isoforms in human tumours.
    Coates PJ
    J Pathol; 2006 Dec; 210(4):385-9. PubMed ID: 17044134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transdominant DeltaTAp73 isoforms are frequently up-regulated in ovarian cancer. Evidence for their role as epigenetic p53 inhibitors in vivo.
    Concin N; Becker K; Slade N; Erster S; Mueller-Holzner E; Ulmer H; Daxenbichler G; Zeimet A; Zeillinger R; Marth C; Moll UM
    Cancer Res; 2004 Apr; 64(7):2449-60. PubMed ID: 15059898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p73 Isoforms affect VEGF, VEGF165b and PEDF expression in human colorectal tumors: VEGF165b downregulation as a marker of poor prognosis.
    Díaz R; Peña C; Silva J; Lorenzo Y; García V; García JM; Sánchez A; Espinosa P; Yuste R; Bonilla F; Domínguez G
    Int J Cancer; 2008 Sep; 123(5):1060-7. PubMed ID: 18546269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic impact of ΔTAp73 isoform levels and their target genes in colon cancer patients.
    Soldevilla B; Díaz R; Silva J; Campos-Martín Y; Muñoz C; García V; García JM; Peña C; Herrera M; Rodriguez M; Gómez I; Mohamed N; Marques MM; Bonilla F; Domínguez G
    Clin Cancer Res; 2011 Sep; 17(18):6029-39. PubMed ID: 21807636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BRCA1-associated epigenetic regulation of p73 mediates an effector pathway for chemosensitivity in ovarian carcinoma.
    Ibrahim N; He L; Leong CO; Xing D; Karlan BY; Swisher EM; Rueda BR; Orsulic S; Ellisen LW
    Cancer Res; 2010 Sep; 70(18):7155-65. PubMed ID: 20807817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanism of p73-mediated regulation of hepatitis B virus core promoter/enhancer II: implications for hepatocarcinogenesis.
    Buhlmann S; Racek T; Schwarz A; Schaefer S; Pützer BM
    J Mol Biol; 2008 Apr; 378(1):20-30. PubMed ID: 18342333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antisense gapmers selectively suppress individual oncogenic p73 splice isoforms and inhibit tumor growth in vivo.
    Emmrich S; Wang W; John K; Li W; Pützer BM
    Mol Cancer; 2009 Aug; 8():61. PubMed ID: 19671150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TAp73 and ΔNp73 have opposing roles in 5-aza-2'-deoxycytidine-induced apoptosis in breast cancer cells.
    Lai J; Yang F; Zhang W; Wang Y; Xu J; Song W; Huang G; Gu J; Guan X
    Mol Cells; 2014 Aug; 37(8):605-12. PubMed ID: 25134538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential regulation of TP73 isoforms by 1α,25-dihydroxyvitamin D3 and survivin in human colon and breast carcinomas.
    Díaz R; González-Sancho JM; Soldevilla B; Silva J; García JM; García V; Peña C; Herrera M; Gómez I; Bonilla F; Domínguez G
    Genes Chromosomes Cancer; 2010 Dec; 49(12):1135-42. PubMed ID: 20842728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of TAp73 and DeltaNp73 isoform transcripts in thyroid tumours.
    Ferru A; Denis S; Guilhot J; Gibelin H; Tourani JM; Kraimps JL; Larsen CJ; Karayan-Tapon L
    Eur J Surg Oncol; 2006 Mar; 32(2):228-30. PubMed ID: 16290057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of DeltaTAp73 proteins by translation from a putative internal ribosome entry site.
    Sayan AE; Roperch JP; Sayan BS; Rossi M; Pinkoski MJ; Knight RA; Willis AE; Melino G
    Ann N Y Acad Sci; 2007 Jan; 1095():315-24. PubMed ID: 17404044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of p73 N-terminal isoform expression and p53 status have prognostic value in gynecological cancers.
    Becker K; Pancoska P; Concin N; Vanden Heuvel K; Slade N; Fischer M; Chalas E; Moll UM
    Int J Oncol; 2006 Oct; 29(4):889-902. PubMed ID: 16964385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DeltaNp73, a dominant-negative inhibitor of wild-type p53 and TAp73, is up-regulated in human tumors.
    Zaika AI; Slade N; Erster SH; Sansome C; Joseph TW; Pearl M; Chalas E; Moll UM
    J Exp Med; 2002 Sep; 196(6):765-80. PubMed ID: 12235210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical relevance of dominant-negative p73 isoforms for responsiveness to chemotherapy and survival in ovarian cancer: evidence for a crucial p53-p73 cross-talk in vivo.
    Concin N; Hofstetter G; Berger A; Gehmacher A; Reimer D; Watrowski R; Tong D; Schuster E; Hefler L; Heim K; Mueller-Holzner E; Marth C; Moll UM; Zeimet AG; Zeillinger R
    Clin Cancer Res; 2005 Dec; 11(23):8372-83. PubMed ID: 16322298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of TAP73 and DeltaNP73 in malignant gliomas.
    Ugur H; Sayan AE; Ozdamar SO; Kanpolat Y; Ozturk M
    Oncol Rep; 2004 Jun; 11(6):1337-41. PubMed ID: 15138575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of increase in transcript levels of Tp73 DeltaEx2-3 isoforms in low-grade glioma patients.
    Wager M; Guilhot J; Blanc JL; Ferrand S; Milin S; Bataille B; Lapierre F; Denis S; Chantereau T; Larsen CJ; Karayan-Tapon L
    Br J Cancer; 2006 Oct; 95(8):1062-9. PubMed ID: 17047653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The diverse oncogenic and tumour suppressor roles of p63 and p73 in cancer: a review by cancer site.
    Orzol P; Holcakova J; Nekulova M; Nenutil R; Vojtesek B; Coates PJ
    Histol Histopathol; 2015 May; 30(5):503-21. PubMed ID: 25510918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.